Objective: To examine the incidence of and the anatomic factors that may contribute to spinal cord ischemia (SCI) in patients with a history of abdominal aortic aneurysms (AAA) after thoracic endovascular aortic repair (TEVAR). Methods: The medical records, computed tomography (CT) angiograms, and a prospectively maintained clinical database of all TEVAR patients at a single institution between 2000 and 2007 were reviewed. Select preoperative demographics, thoracoabdominal aortoiliac anatomy, intraoperative procedural variables, and postoperative outcomes were examined. Univariate and multivariate analyses were performed and odds ratio estimates were reported with 95% confidence intervals. Results: Of the 261 patients who underwent TEVAR, 27 developed SCI (10%). Thirteen (48%) of these 27 patients were completely reversed with spinal drainage, and 14 (52%) were permanent. Patients with SCI tended to be older (P ‫؍‬ .006), male (P ‫؍‬ .049), and required more emergent procedures (P ‫؍‬ .051) performed under general anesthesia (P ‫؍‬ .004). Interestingly, while prior AAA repair (50/261, 19%) alone was not associated with SCI (P ‫؍‬ .44), a history of either repaired or unrepaired AAA (101/261, 39%) was a predictor of SCI on multivariate analysis (odds ratio [OR] ‫؍‬ 4.35 [1.43, 14.3], P ‫؍‬ .10), independent of thoracic aortic coverage (P ‫؍‬ .001) and lumbar artery patency (P ‫؍‬ .008), both of which were also associated with SCI. Conclusion: Although the causes of SCI after TEVAR are multifactorial, abdominal aortic anatomy appears to be associated with development of this complication. Patients with either prior AAA repair or those with unrepaired AAA appear to be at increased risk for SCI. ( J Vasc Surg 2009;49:302-7.) From the Divisions of Vascular Surgery and Endovascular Therapy a and Thoracic and Cardiovascular Surgery,
Spinal cord ischemia (SCI) is a devastating complication in patients undergoing surgical or endovascular repair of the thoracic aorta. The incidence of SCI has been reported to be between 0-14% for patients undergoing thoracic endovascular aortic repair (TEVAR). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Perioperative risk factors contributing to this complication have been reported to include length of aortic coverage, 8, 10, 12 prior abdominal aortic aneurysm (AAA) repair, 1, 5, 7 hypotension, 3, 13, 14 and left subclavian artery coverage. [15] [16] [17] [18] Although the putative mechanism of loss of lumbar collateral perfusion in those who had prior aortic repairs appears reasonable, occurrence of SCI in this subset of patients has not been consistent. In this study, we examined the incidence of and the anatomic factors that may contribute to SCI in patients with a history of AAAs after TEVAR.
METHODS

Between September 2000 and September 2007, 261
TEVARs were performed at a single tertiary-care university medical center. We retrospectively reviewed a prospectively maintained thoracic endovascular database, as well as the medical records and imaging studies of all patients who underwent stent graft repair of their thoracic aorta. Preoperative demographics and thoracoabdominal aortoiliac anatomy, intraoperative procedure-related measures, device usage, and postoperative outcomes were assessed. This study had been approved by the Institutional Review Board.
All patients underwent preoperative and postoperative computed tomographic angiography (CTA) (Toshiba Aquilion, Tustin, Calif, 16-64 multislice detectors depending on the year of the study) using a timed-bolus, intravenous contrast technique acquired at 2-3 mm collimations. The dataset was then reconstructed and post-processed using the Aquarius Workstation (TeraRecon, San Mateo, Calif). This was used to assess preoperative aortoiliac morphology, dimensions, branch vessel patency, and postoperative aortic coverage.
An AAA was defined using a maximum transverse aortic diameter of Ն30 mm. Although this definition may seem arbitrary, the 30-mm threshold has numerous precedents in the published literature and has been more commonly used than the 1.5X diameter of adjacent "normal" artery criterion. [19] [20] [21] [22] [23] Furthermore, all of the aneurysms showed focal dilation of the aorta and did not simply represent ectasia or arteriomegaly.
SCI was defined as any new lower extremity motor and/or sensory deficit. It was considered "transient" (vs "permanent") when a clear deficit was documented and then completely reversed to the patient's baseline functional status. Even when a patient's symptoms had improved but his or her functional status was not restored to preoperative levels, the complication was considered "permanent".
Prophylactic spinal drainage was primarily based on operator preference and no clear protocol was followed during the study period. The only exceptions to this practice included patients who had focal pathologies, such as penetrating ulcers or traumatic transections, and required Յ10 cm of thoracic coverage or had coagulopathy (international normalized ratio, [INR] Ͼ1.3) that could not be corrected in a timely manner precluding safe placement of a spinal catheter.
All patients were admitted postoperatively to the Cardiac Intensive Care Unit, where neurologic exams were performed hourly. Upon detection of symptoms, the blood pressure was elevated to a systolic pressure of Ͼ160 mm Hg (mean arterial pressure of Ͼ100 mm Hg) with vasopressors, and a spinal catheter was promptly (Ͻ2 hours of symptoms) placed by a qualified cardiac anesthesiologist (in those patients who were not drained preoperatively). The spinal drainage catheter was placed at 10 cm above the level of the heart and adjusted higher or lower depending on the amount of spinal fluid drainage and therapeutic effect. The catheter was left in place for 72 hours. After reversal of SCI, the catheter was clamped for another 24 hours in case the symptoms returned, and then removed.
Continuous data were analyzed using a two-tailed t test and categorical variables using Fisher's exact test, with P Ͻ .05 considered statistically significant. Univariate and multivariate logistic regression models were constructed using a set of 20 potential predictors: age, gender, BMI (body mass index), American Society of Anesthesiologists (ASA) classification, type, maximum diameter, and length of thoracic aortic pathology being treated, endograft type, history of AAA repair, lumbar and hypogastric artery patency, left subclavian artery (LSA) coverage, urgency of the procedure, preoperative spinal drainage, anesthetic technique, iliac conduit, thoracic aortic length (from left common carotid artery to celiac artery) and endograft coverage, duration of procedure, and blood loss. Odds ratio estimates were reported with 95% confidence intervals.
RESULTS
Of the 261 patients who underwent TEVAR, 67% (176/261) were men and the mean age was 66.2 Ϯ 15.2 years with a BMI of 26.8 Ϯ 5.5 kg/m 2 . The majority of the patients were designated as ASA IV (160/261, 61%) and had either degenerative aneurysms (52%, 136/261) or dissections (21%, 55/261). The TAG endograft (W. L. Gore, Flagstaff, Ariz) was the only commercially-available thoracic aortic device during the study period and, therefore, 78% (204/261) patients were repaired using this system, with the balance comprised of investigational devices. Eighty-eight (34%) of the 261 procedures were performed emergently for acute or symptomatic conditions, such as ruptures or complicated dissections, and general anesthesia was used in 69% (179/261) cases. Iliac conduits were required in 19% (50/261) of cases and only 12% (31/261) had prophylactic spinal drainage. The mean du-ration of the procedures was 113 Ϯ 67 minutes and blood loss 308 Ϯ 365 mL. Overall, there were 33 intraoperative complications in 27 patients for an event rate of 10.3% and 1.2 events/person (Table I) . Postoperatively, there were 177 30-day or in-hospital complications in 92 patients for an overall rate of 35% and 1.9 events/patient. Early mortality was 6.5% (17/261) (Table II) .
SCI occurred in 10.3% (27/261) of cases. Thirteen (48.1%) were completely reversed with spinal drainage, and 14 (51.9%) were permanent. Patients who developed SCI were older (74 Ϯ 9 vs 65 Ϯ 16 years, P ϭ .006), had a higher proportion of men (85% vs 65%, P ϭ .049), lower BMI (23.6 vs 27.0 kg/m 2 , P ϭ .003), more emergent procedures (52% vs 32%, P ϭ .051) performed under general anesthesia (93% vs 66%, P ϭ .004), and longer operating times (143 Ϯ 79 vs 110 Ϯ 65 minutes, P ϭ .014) than those who did not have SCI. However, there were no significant differences in the ASA class, endograft type, intraoperative blood loss, incidence of LSA coverage, use of iliac conduits, or prophylactic spinal drainage between the two cohorts (Table III) .
The mean length of the thoracic aorta for the entire group was 289 Ϯ 39 mm. Patients with SCI had a larger maximum thoracic aortic diameter (P ϭ .014), longer thoracic aortic length (P ϭ .036), and higher fractional endograft coverage of their thoracic aorta (P ϭ .0001) than (Table IV) . Axial images from 254 preoperative CTA were serially reviewed from the celiac artery to the aortic bifurcation and the number of patent lumbar and hypogastric arteries counted. Seven scans were unavailable for analysis. The mean number of patent lumbar arteries was significantly lower in the SCI group compared to the no-SCI group (P ϭ .008), while hypogastric artery patency was similar (Fig) . Univariate analysis showed that each additional patent lumbar artery conferred approximately a 17% reduction in the risk of SCI.
Multivariate logistic regression analysis was performed to eliminate potential confounders. Again, a history of either repaired or unrepaired AAA was highly independently predictive of SCI (OR ϭ 4.35 [1.43, 14.3] , P ϭ .10). Other variables which remained independently associated with SCI included extent of thoracic aortic coverage (OR ϭ 2.0 [1.3, 3.1], P ϭ .002, for every 10% or ϳ2.9 cm incremental coverage) and general anesthesia (OR ϭ 7.7 [1.6, 37], P ϭ .012).
DISCUSSION
Endovascular repair has become a minimally-invasive alternative to the treatment of a variety of thoracic aortic pathologies with decreased perioperative mortality, respira-tory failure, renal insufficiency, and hospital stay compared to open repair. [24] [25] [26] Spinal cord ischemia after endovascular repair is a devastating complication whose occurrence has been difficult to predict preoperatively. One of the risk factors that has been previously reported to be associated with SCI has been prior AAA repair. 1, 5, 7 In this study, we showed that not prior AAA repair, per se, but rather a history of either repaired or unrepaired AAA was associated with SCI. Our finding is consistent with the recent report by Baril et al 1 who also noted an increased incidence of SCI in patients with concomitant AAA or previously repaired AAA (14.3%) vs patients with no AAA (1.0%). In our study, the incidence of SCI in patients with either repaired or unrepaired AAA was 18% (18/101) vs 6% (9/160) in patients without any history of AAA (P ϭ .003). Unlike in aortoiliac occlusive disease where many of the lumbar arteries are frequently patent and enlarged serving as important collateral supply to the pelvis, in patients with AAA one or more lumbar arteries are occluded. Indeed, the mean number of lumbar arteries in those with a history of AAA (repaired or unrepaired) was significantly less than in those without an AAA (4.5 Ϯ 3.0 vs 7.6 Ϯ 1.3, P Ͻ .0001), and 78% of the former cohort had at least two occluded lumbar arteries. On the other hand, as shown by the multivariate analysis, decreased lumbar artery perfusion alone does not account for the pathophysiology of SCI in patients with unrepaired AAA.
Above and beyond its association with AAA, patients with SCI had a decreased number of patent lumbar arteries compared to those who did not develop SCI. The incidence of SCI was 22% (13/59) if there were less than five patent lumbar arteries compared to 6.7% (13/195 ) in those who had five or more (P ϭ .002). A limitation of our CTA-based analysis is that identification of patent arteries is obviously dependent on the technique and quality of the image acquisition. The possibility of inadequate contrast delivery to a lumbar artery resulting in the appearance of an occluded vessel cannot be ruled out, as well as the failure to detect smaller lumbar vessels (Ͻ1 mm) and differentiation between direct vs collateral perfusion.
Finally, despite numerous prior publications suggesting an association between LSA coverage and SCI, [15] [16] [17] [18] 27 neither our study nor the one by Amabile et al 28 found such a correlation. In the current series, SCI occurred in 11% (18/161) of those with and in 9% (9/100) of those without a patent LSA (P ϭ .68). Despite its apparent anatomic basis, the actual contribution to overall spinal cord perfusion by one or both vertebral arteries via the anterior spinal artery is difficult to determine, and we do not believe justifies prophylactic revascularization in every case of LSA coverage. Currently, the main indications in our practice for preoperative subclavian artery bypass include a dominant left vertebral artery with a diminutive right vertebral artery and/or a patent left internal mammary artery (LIMA) graft to the left anterior descending (LAD) coronary artery. To this end, CTA imaging of the intracranial circulation is routinely performed as part of our preoperative imaging protocol. The incidence of symptomatic left arm claudication is extremely small. Of the 115 of 261 (44%) cases that had LSA coverage, 7 had prophylactic preoperative revascularizations and only 2 (1.7%) required LSA bypass for upper extremity ischemia.
CONCLUSION
Symptoms of SCI can occur in up to 10% of those undergoing TEVAR, only about half of which are permanent. Patients with a history of either repaired or unrepaired AAA face over four times increased risk of developing SCI as compared to those without an AAA and is independent of the length of thoracic aorta covered. Prophylactic measures for spinal cord protection should be considered in the subset of individuals with this preoperative risk factor. 
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Spinal cord ischemia (SCI) is clearly one of the more devastating complications after the repair of any thoracic pathology by any means. The multifactorial etiology of the complication has so far resulted in a variety of management strategies that have failed to garner uniform adoption. Endografting of thoracic aneurysms (TEVAR) was greeted with the expectation that this feared outcome would be diminished by avoiding aortic clamping and prolonged ischemia of the cord. This optimism appears well justified by most early published results, as SCI seems to occur in Ͻ5% of cases and mostly in aneurysmal pathology of the thoracic aorta and less so with dissection or transection. [1] [2] [3] [4] In an effort to further limit the occurrence of SCI, a diligent search for predisposing risk factors has so far resulted in a myriad of associations with little consensus about the relative importance of any. Notable suspects include length of thoracic aortic coverage, left subclavian artery exclusion without reconstruction, elimination of intercostal blood supply, especially the artery of Adamkiewicz, poor lumbar and internal iliac artery collaterals, intraoperative hypotension, conduit use for access, and underlying aneurysmal pathology. The presence of a concurrent or remotely repaired abdominal aortic aneurysm (AAA) has also been repeatedly implicated, with only sparse supporting evidence.
This issue of the Journal of Vascular Surgery brings the reader two reports focusing on the risk of SCI after TEVAR in patients with AAA. The reports differ in methodology, results, patient population, and extent of use of prophylactic spinal drainage, yet are remarkably similar in the estimated risk of SCI in patients with prior AAA repair: 12.5% in a multicenter study limited to thoracic aneurysms and 14% in a single-center series with a potpourri of diagnoses. The incidence is notably the same as that reported in a smaller series by Baril in 2006. 5 Despite the inherent methodologic problems of all these retrospective analyses, and other negative reports, the evidence is mounting that SCI risk is elevated after TEVAR in patients with remote aneurysm repair. The incidence of SCI seems to be significantly higher in this patient subgroup irrespective of other risk factors that may exist. The SCI hazard ratio in patients with AAA seems to range between 4 and 7.
The report from the University of Florida by Martin indicates an even more alarming SCI rate of 21% in 51 patients with untreated concurrent AAA as small as 3.0 cm in diameter, a size rarely considered an aneurysm in most clinical settings. This finding adds another dimension to the association of SCI with any current aneurysmal pathology of the abdominal aorta and clearly constitutes a cause for concern in the preoperative risk benefit assessment before TEVAR.
The rest of the information provided by these two studies is somewhat disparate due to different methodology and inclusion criteria. The multicenter study by Schlosser reports a somewhat enviable SCI rate of only 1.7% after TEVAR for thoracic aneurysms in the absence of prior AAA repair. In the absence of any abdominal aortic pathology, Martin still reports a rate of 5.6% in a more diverse group including patients with dissections, transections, and other pathologies that would have been expected to lower the incidence of this complication.
An SCI rate of Ͼ10% in the entire TEVAR series from a group with a large experience such as the University of Florida is quite sobering, pointing out that we have a long way to go before understanding all the factors that may influence the development of this debilitating complication. The contributions of emergency interventions as well as hybrid procedures to this elevated risk is not entirely clear from the data presented. Prospective focused collection of data may be required before providing guidelines for the proper selection of patients and conduct of the operation to minimize these unfortunate outcomes.
In the meantime these two studies provide a strong reminder that caution should be exercised when offering TEVAR to a large group of patients who present with remote or concurrent AAA. A careful analysis of the risk/benefit ratio under these circumstances should lead us to only offer TEVAR to patients with a higher risk profile of the underlying pathology, raising the size threshold for intervention on aneurysmal disease of the thoracic aorta.
